Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early intervention in heart failure.

M A Creager1

  • 1Brigham and Women's Hospital, Harvard Medical School, Boston.

Drugs
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Early intervention with angiotensin-converting enzyme (ACE) inhibitors may improve exercise performance and reduce mortality in heart failure patients. Research suggests ACE inhibitors could prevent disease progression in those with asymptomatic left ventricular dysfunction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.

Current medical research and opinion·2008
Same author

The role of total and high-molecular-weight complex of adiponectin in vascular function in offspring whose parents both had type 2 diabetes.

Diabetologia·2005
Same author

Beta-blockers for vascular surgery and angioplasty for renal artery stenosis.

Reviews in cardiovascular medicine·2003
Same author

Takayasu arteritis.

Reviews in cardiovascular medicine·2002
Same author

Percutaneous interventions for lower-extremity peripheral atherosclerotic disease.

Reviews in cardiovascular medicine·2002
Same author

Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication.

Vascular medicine (London, England)·2002

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Congestive heart failure (CHF) treatment focuses on symptom reduction and functional capacity improvement.
  • Current therapies for moderate to severe CHF include diuretics, digoxin, and vasodilators like ACE inhibitors.
  • These interventions target left ventricular dysfunction, vasoconstriction, and fluid retention.

Purpose of the Study:

  • To explore the benefits of early therapeutic interventions in heart failure.
  • To investigate the impact of vasodilator therapy, specifically ACE inhibitors, on mild heart failure symptoms.
  • To assess the potential of ACE inhibitors in preventing disease progression in asymptomatic left ventricular dysfunction.

Main Methods:

  • Review of current therapeutic strategies for congestive heart failure.

Related Experiment Videos

  • Analysis of studies on vasodilator therapy in patients with mild heart failure symptoms.
  • Examination of research on ACE inhibitors for asymptomatic left ventricular dysfunction.

    • Main Results:

    • Vasodilator therapy in mild heart failure may enhance exercise performance and decrease mortality.
    • ACE inhibitors show potential in halting disease progression in patients with asymptomatic left ventricular dysfunction.

    Conclusions:

    • Early identification and treatment of heart failure are crucial.
    • ACE inhibitors may play a significant role in preventing symptom development and improving survival in CHF patients.
    • Ongoing research aims to confirm the long-term benefits of early ACE inhibitor use.